Potassium Citrate Monohydrate Powder Descriptions:
Potassium Citrate Monohydrate Powder (CAS 6100-05-6) is a white crystalline powder. It is readily soluble in water; its aqueous solution is alkaline with a pH of 8.5. It is slowly soluble in glycerin and almost insoluble in ethanol.
Potassium Citrate Monohydrate Powder may be used as a food additive. It is used in the pharmaceutical industry for treating hypokalaemia, potassium deficiency and for urine alkalisation. Consequently, it reduces the acid level in urine and is used in the management of kidney disease and gout. Moreover, it may be processed into high-efficiency multi-nutrient fertilisers and employed in paper manufacturing, gilding and other industries.
Specifications for Potassium Citrate Monohydrate Powder:
Chemical Data
|
Chemical Formula
|
K3C6H5O7-H2O
|
CAS No.
|
6100-05-6
|
Molecular Weight
|
324.41
|
Applications
|
Nutrient; Dietary Supplement; Pharmaceuticals
|
Description
|
White Powder
|
Storage
|
Store in a clean, dry warehouse in the unopened original containers
|
|
Chemical Specifications
|
Determination
|
99.0-101.0%
|
LOD
|
3.0-6.0%
|
Oxalate
|
Test to pass
|
Sulphate
|
0.15% maximum
|
Chloride
|
Maximum 350 ppm
|
pH
|
As per test
|
Slightly Carbonising Matter
|
Test to pass
|
Heavy Metals (Pb)
|
10 ppm maximum
|
Arsenic
|
2 ppm maximum
|
Bulk Density
|
As per customer requirements
|
|
Potassium Citrate Monohydrate Powder Applications:
Potassium Citrate Monohydrate Powder may be used as a food additive. It is used in the pharmaceutical industry for hypokalaemia, potassium deficiency and urine alkalisation. Consequently, it helps reduce the acid content in urine and is used in the management of kidney disease and gout. Moreover, it may be processed into high-efficiency multi-nutrient fertilisers and employed in paper manufacturing, gilding and other industries.
Potassium Citrate Monohydrate Powder Safety Information:
Personal Protective Equipment
|
Eye protection, gloves, N95 type (US)
|
RIDADR
|
NONH for all transport modes
|
WGK Deutschland
|
1
|